Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Karpen, SJ; Trauner, M.
The new therapeutic frontier--nuclear receptors and the liver.
J Hepatol. 2010; 52(3):455-462
Doi: 10.1016/j.jhep.2009.12.002
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Trauner Michael
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- A joint EASL/AASLD Monothematic Conference on 'Nuclear Receptors and Liver Disease' was held from February 27th to March 1st, 2009, in Vienna, Austria, to discuss the latest advances at the forefront of basic and clinical nuclear receptor research and its potential implications for liver diseases. This article reports the highlights of the conference and summarizes the main conclusions emphasizing the relevance for clinical and experimental hepatology. The confluence of nuclear receptors as central transcriptional regulators, acting as sensors and adaptors to many of the small molecules present in the intracellular milieu of all the cells of the liver, provides a current framework to address a broader physiological understanding of the liver. The next stage will be the design and testing of safe and effective therapeutics.
- Find related publications in this database (using NLM MeSH Indexing)
-
Humans -
-
Inflammation - physiopathology
-
Lipid Metabolism - physiology
-
Liver - physiology
-
Liver Diseases - physiopathology Liver Diseases - therapy
-
Liver Regeneration - physiology
-
Metabolic Detoxication, Drug - physiology
-
Polymorphism, Genetic - physiology
-
Receptors, Cytoplasmic and Nuclear - genetics Receptors, Cytoplasmic and Nuclear - physiology
-
Transcription Factors - physiology
- Find related publications in this database (Keywords)
-
Nuclear receptor
-
Ligand
-
Gene expression
-
Cholestasis
-
Fatty liver
-
Fibrosis